Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.88 -0.08 (-8.65%)
As of: Sep 30, 2026 · 2:36 PM EDT

Alaunos Therapeutics (TCRT) Share-based Compensation (2009 - 2026)

Updated

Alaunos Therapeutics' Share-based Compensation came in at $246,000 for Q2 2026, up 33.0% from $185,000 a year earlier and up 74.5% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Share-based Compensation (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alaunos Therapeutics reported Share-based Compensation of $931,000, up 124.9% year-over-year; for FY2025, it came in at $796,000, up 83.0% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of -34.9% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $435,000 in FY2024 (-84.5%), $2.8 million in FY2023 (-20.6%), $3.53 million in FY2022 (-67.3%) and $10.77 million in FY2021 (+57.8%).
  • The five-year range for quarterly Share-based Compensation is $68,000 (Q1 2025) to $2.37 million (Q3 2021).
  • Year-over-year, Share-based Compensation has increased for five consecutive quarters, with growth averaging 60.3% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q3 2025 (growth of 276.3%), and the weakest in Q3 2024 (a decline of 89.0%).
  • Business Quant data shows TCRT's Share-based Compensation at $141,000 (Q1 2026), $243,000 (Q4 2025) and $301,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 458.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 166.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 170.20 Mn
10 Alaunos Therapeutics 2.39 Mn -1.41 Mn - 246,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 246,000.00
Mar 31, 2026 141,000.00
Dec 31, 2025 243,000.00
Sep 30, 2025 301,000.00
Jun 30, 2025 185,000.00
Mar 31, 2025 68,000.00
Dec 31, 2024 81,000.00
Sep 30, 2024 80,000.00
Jun 30, 2024 101,000.00
Mar 31, 2024 172,000.00
Dec 31, 2023 250,000.00
Sep 30, 2023 726,000.00
Jun 30, 2023 914,000.00
Mar 31, 2023 910,000.00
Dec 31, 2022 877,000.00
Sep 30, 2022 808,000.00
Jun 30, 2022 990,000.00
Mar 31, 2022 853,000.00
Dec 31, 2021 917,000.00
Sep 30, 2021 2.37 Mn
API Access

Alaunos Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TCRT&period=max&api_key=YOUR_API_KEY